A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non‐Small Cell Lung Cancer

Gefitinib, Erlotinib, Osimertinib, Epidermal growth factor receptor, EGFR inhibitors, Cancer research, Afatinib, Neratinib, T790M, ERBB3, Lung cancer, Medicine, ErbB, Tyrosine kinase, ERBB4, Receptor tyrosine kinase, Cancer, Oncology, Trastuzumab, Receptor, Internal medicine, Breast cancer